Signaling pathways
-
BA5908 TepoxalinSummary: Tepoxalin is a dual inhibitor of cyclooxygenase (COX) and 5-lipoxygenase (5-LO). -
BA5909 MacelignanSummary: Macelignan ((+)-Anwulignan; Anwuligan) is a bioactive lignan isolated from nutmeg.
-
BA5910 LoxoprofenSummary: Loxoprofen is an orally active and antipyretic nonsteroidal anti-inflammatory drug studied for pain relief. -
BA5911 HexahydrocurcuminSummary: Hexahydrocurcumin, one of the major metabolites of curcumin, is a selective inhibitor of oral activity.
-
BA5913 TFAPSummary: TFAP is a selective inhibitor of cyclooxygenase 1.
-
BA5914 CP-74006Summary: A selective inhibitor.
-
BA5915 PolmacoxibSummary: A first-in-class, orally active COX-2 and carbonic anhydrase dual inhibitor (NSAID) that inhibits colorectal adenoma and tumor growth -
BA5916 SphondinSummary: Inhibitory effect on IL-1β-induced elevation of protein and PGE release levels in A549 cells.
-
BA5917 EnflicoxibSummary: Enflicoxib (E6087) is a nonsteroidal anti-inflammatory compound that selectively inhibits cyclooxygenase 2.
-
BA5918 IsoxicamSummary: Isoxicam is a potent, orally active non-steroidal anti-inflammatory agent for use in arthritis research.